441 related articles for article (PubMed ID: 18850474)
81. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
82. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
de Mingo M; Morán A; Sánchez-Pernaute A; Iniesta P; Díez-Valladares L; Pérez-Aguirre E; de Juan C; García-Aranda C; Díaz-López A; García-Botella A; Martín-Antona E; Benito M; Torres A; Balibrea JL
Hepatogastroenterology; 2007; 54(73):315-9. PubMed ID: 17419282
[TBL] [Abstract][Full Text] [Related]
83. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
84. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
85. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H
J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677
[TBL] [Abstract][Full Text] [Related]
86. Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.
Yamaguchi H; Kidachi Y; Umetsu H; Ryoyama K
Cell Biol Int; 2008 Aug; 32(8):940-9. PubMed ID: 18474440
[TBL] [Abstract][Full Text] [Related]
87. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Elliott MB; Welliver RC; Laughlin TS; Pryharski KS; LaPierre NA; Chen T; Souza V; Terio NB; Hancock GE
J Med Virol; 2007 Apr; 79(4):447-56. PubMed ID: 17311330
[TBL] [Abstract][Full Text] [Related]
88. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
89. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.
Kyaw-Tanner MT; Wattle O; van Eps AW; Pollitt CC
Equine Vet J; 2008 Jul; 40(5):482-7. PubMed ID: 18178538
[TBL] [Abstract][Full Text] [Related]
90. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
91. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Górska R; Nedzi-Góra M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880
[TBL] [Abstract][Full Text] [Related]
92. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
Sunagawa S; Ichiyama T; Honda R; Fukunaga S; Maeba S; Furukawa S
Brain Dev; 2009 Sep; 31(8):588-93. PubMed ID: 18849127
[TBL] [Abstract][Full Text] [Related]
93. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
94. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
Ikonomidis JS; Gibson WC; Butler JE; McClister DM; Sweterlitsch SE; Thompson RP; Mukherjee R; Spinale FG
Circulation; 2004 Sep; 110(11 Suppl 1):II268-73. PubMed ID: 15364874
[TBL] [Abstract][Full Text] [Related]
95. Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
Strååt K; de Klark R; Gredmark-Russ S; Eriksson P; Söderberg-Nauclér C
J Virol; 2009 Jan; 83(2):830-5. PubMed ID: 18945772
[TBL] [Abstract][Full Text] [Related]
96. Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis.
Gröters S; Alldinger S; Baumgärtner W
Acta Neuropathol; 2005 Oct; 110(4):369-82. PubMed ID: 16133545
[TBL] [Abstract][Full Text] [Related]
97. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
[TBL] [Abstract][Full Text] [Related]
98. Identification of a calcium-dependent matrix metalloproteinase complex in rat chorioallantoid membranes during labour.
Meraz-Cruz N; Ortega A; Estrada-Gutierrez G; Flores A; Espejel A; Hernandez-Guerrero C; Vadillo-Ortega F
Mol Hum Reprod; 2006 Oct; 12(10):633-41. PubMed ID: 16935996
[TBL] [Abstract][Full Text] [Related]
99. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
100. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Tazaki T; Minoguchi K; Yokoe T; Samson KT; Minoguchi H; Tanaka A; Watanabe Y; Adachi M
Am J Respir Crit Care Med; 2004 Dec; 170(12):1354-9. PubMed ID: 15361365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
